What is a brain pacemaker (DBS)? DBS Deep Brain Stimulation (commonly known as: Brain Pacemaker) is the biggest breakthrough in the treatment of Parkinson’s disease therapy. The pacemaker is implanted in the body to stimulate the nuclei in the brain that control movement, thereby improving the symptoms of Parkinson’s disease and allowing the patient to regain freedom of movement and self-care. Brain pacemaker is the application of minimally invasive neurosurgical techniques, after the patient’s brain is accurately located, the extremely thin electrodes, placed in specific parts of the brain, and then the electrodes are connected to a matchbox-sized microcomputer stimulator, through which personalized electrical signals are sent to restore the patient’s abnormal activities to a coordinated state. And the installation of the electrodes neither damages the brain nor changes any structure of the brain. The microcomputerized stimulator is implanted under the chest skin through the patient’s subcutaneous “tunnel”. By adjusting the parameters of the microcomputer stimulator, the patient can return to a normal or near-normal state of life. How does the pacemaker work? Deep brain electrical stimulation uses electrodes implanted in the brain to send weak electrical impulses to the relevant nuclei that control movement, modulating abnormal nerve activity and reducing and/or controlling symptoms. Which patients are suitable for pacemaker therapy? Patients with advanced Parkinson’s disease who have been diagnosed with the disease, who are or have been treated with levodopa-based medications (Methyldopa, Xenical), but whose efficacy has declined or who are experiencing side effects, and whose disease has begun to interfere with their normal work and life, are suitable for this therapy. To ensure the efficacy of the treatment, a series of evaluations will be carried out to take into account all the influencing factors related to the disease and to exclude patients who do not meet the indications for the procedure in order to ensure the efficacy of the treatment. The success of brain pacing therapy depends on proper patient selection, evaluation, precise surgical targeting and implantation of electrodes, and postoperative control. Brain pacing therapy has been shown to be most effective in patients with the following diagnoses and symptoms: * Patients with primary Parkinson’s disease who are or have been effective on levodopa; * Patients with diminished efficacy of anti-Parkinson’s disease medications or unacceptable side effects; * Patients with motor symptoms that result in significant dysfunction; * Patients who are physically and mentally fit for surgical intervention; * Patients with idiopathic tremor; * Patients with primary torsion patients with primary torsion spasms. Is the procedure for Brain Pacemaker Therapy safe? With the help of precise stereotactic minimally invasive surgery, brain pacemakers can be implanted smoothly into the body. This procedure is safe, minimally invasive, does not destroy brain tissue, and avoids irreversible and serious complications due to destruction of the nucleus pulposus. The side effects of brain pacemakers are few and mild. During brain pacing therapy implantation, the patient is conscious and the physician tests the stimulation effect to obtain maximum suppression of Parkinson’s disease symptoms with minimal side effects. Brain pacing therapy does not affect cognitive function, does not cause brain tissue damage, is well tolerated, and most side effects are transient and can be controlled by adjusting the stimulation parameters. What is the typical length of hospitalization before surgery, surgery and recovery time? The length of hospitalization varies from person to person, but on average it takes about 2 weeks from the time of pre-surgical hospitalization, surgery and discharge from the hospital.